Cite
Chey SY, Kermode AG. Central Nervous System Demyelination Related to Tumour Necrosis Factor Alpha Inhibitor. Mult Scler J Exp Transl Clin. 2022;8(1):20552173211070750doi: 10.1177/20552173211070750.
Chey, S. Y., & Kermode, A. G. (2022). Central Nervous System Demyelination Related to Tumour Necrosis Factor Alpha Inhibitor. Multiple sclerosis journal - experimental, translational and clinical, 8(1), 20552173211070750. https://doi.org/10.1177/20552173211070750
Chey, Shin Yee, and Kermode, Allan G. "Central Nervous System Demyelination Related to Tumour Necrosis Factor Alpha Inhibitor." Multiple sclerosis journal - experimental, translational and clinical vol. 8,1 (2022): 20552173211070750. doi: https://doi.org/10.1177/20552173211070750
Chey SY, Kermode AG. Central Nervous System Demyelination Related to Tumour Necrosis Factor Alpha Inhibitor. Mult Scler J Exp Transl Clin. 2022 Jan 05;8(1):20552173211070750. doi: 10.1177/20552173211070750. eCollection 2022. PMID: 35024163; PMCID: PMC8743963.
Copy
Download .nbib